Bod Australia |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 6:58am | ||||
|
Market Cap (13-Nov) $28,597,052 (1,494th) |
Close (18-Oct) $0.270 |
Volume (18-Oct) 0 |
Shortsold (25-Oct) 26,980 (0.03%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.043 |
212% increase in medicinal cannabis product sales in FY2021
BDA released this announcement to the ASX on 1 July 2021, 9:08. The announcement is marked as price sensitive, and is 2 page(s) in length and 603.42kb in size.
You can view all announcements from BDA and see how they appear on a price chart on the announcements page.
At the date of this announcement, BDA was 0.187% short sold according to ASIC data. It was ranked the 383rd most shorted stock on the ASX. It remains ranked 544th as of the latest reported data (25 October 2021).
| Other Recent Announcements from BDA | |
|---|---|
| Change of ASX code to BOD | 15 October 2021, 13:23 |
| BOD to conduct Schedule 3 clinical trial of new CBD product | 22 September 2021, 9:14 |
| Change in substantial holding | 27 August 2021, 18:58 |
| 212% increase in medicinal cannabis product sales in FY2021 | 1 July 2021, 9:08 |
| Bod broadens UK sales footprint | 17 June 2021, 9:49 |
| Results of Meeting | 4 June 2021, 14:11 |
| Launch of new medicinal cannabis product and UK update | 18 May 2021, 9:44 |
If you were already registered, log in here.